Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1691-1697

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scherberich, A.
Right arrow Articles by Beretz, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scherberich, A.
Right arrow Articles by Beretz, A.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1691-1697.)
© 1998 American Heart Association, Inc.


Original Contributions

Tetraspanin CD9 Is Associated With Very Late–Acting Integrins in Human Vascular Smooth Muscle Cells and Modulates Collagen Matrix Reorganization

Arnaud Scherberich; Sylvie Moog; Gisèle Haan-Archipoff; David O. Azorsa; François Lanza; ; Alain Beretz

From the Laboratoire de Pharmacologie et Physiologie Cellulaires, ERS CNRS 653, Faculté de Pharmacie, Université Louis Pasteur de Strasbourg, Illkirch (A.S., A.B.); INSERM U 311, Etablissement de Transfusion Sanguine, Strasbourg (S.M., D.O.A., F.L.); and Laboratoire de Pharmacognosie, Faculté de Pharmacie, Université Louis Pasteur de Strasbourg, Illkirch (G.H.-A.), France.

Correspondence to Alain Beretz, Faculté de Pharmacie, BP24, 67401 Illkirch, France. E-mail aberetz{at}pharma.u-strasbg.fr

Abstract—CD9, a member of the tetraspanin family, and very late–acting (VLA) integrins are known to associate and form functional units on the surface of several cell types. We studied the changes in expression of CD9 and ß1-integrins (CD29, VLA) in human vascular smooth muscle cells (VSMCs) under in vitro culture conditions mimicking proliferative vascular diseases. We also investigated possible interactions between CD9 and VLA integrins in VSMCs. We found that CD9 is highly expressed in VSMCs and is subject to modulation, depending on the proliferative/contractile state of the cells. In the contractile phenotype, the levels of CD9, CD81, another tetraspanin, and CD29 are {approx}50% of those found in the proliferative phenotype. Coimmunoprecipitation experiments showed physical association between CD9 and CD29. CD9 was mainly associated with {alpha}2 and {alpha}3-integrins (CD49b and c) and also with {alpha}5-integrin to a weaker extent. Functionally, the addition of anti-CD9 monoclonal antibodies (MoAbs) doubled the extent of collagen gel contraction mediated by VSMCs, a model for the reorganization of the extracellular collagen matrix occurring in the vessel wall. Anti-CD29 MoAbs inhibited gel contraction, but anti-CD9 MoAbs counteracted this inhibitory effect of anti-CD29 MoAbs. Transfection of human CD9 into Chinese hamster ovary cells more than doubled the extent of Chinese hamster ovary cell–mediated collagen gel contraction (130% stimulation), confirming a role for CD9 in extracellular matrix reorganization. Thus, CD9 seems to be involved in the modulation of VLA integrin–mediated collagen matrix reorganization by VSMCs. These findings suggest that high CD9 expression is associated with a proliferative state of VSMCs. The role of CD9 could be to modulate the function of VLA integrins on the surface of VSMCs.


Key Words: CD9 • tetraspanins • collagen • integrins • smooth muscle




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Zhang, J. Kotha, L. K. Jennings, and X. A. Zhang
Tetraspanins and vascular functions
Cardiovasc Res, July 1, 2009; 83(1): 7 - 15.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. R. Clemmons and L. A. Maile
Interaction between Insulin-Like Growth Factor-I Receptor and {alpha}V{beta}3 Integrin Linked Signaling Pathways: Cellular Responses to Changes in Multiple Signaling Inputs
Mol. Endocrinol., January 1, 2005; 19(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
H. Wang, W. Fu, J. H. Im, Z. Zhou, S. A. Santoro, V. Iyer, C. M. DiPersio, Q.-C. Yu, V. Quaranta, A. Al-Mehdi, et al.
Tumor cell {alpha}3{beta}1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis
J. Cell Biol., March 15, 2004; 164(6): 935 - 941.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Herlevsen, D.-S. Schmidt, K. Miyazaki, and M. Zoller
The association of the tetraspanin D6.1A with the {alpha}6{beta}4 integrin supports cell motility and liver metastasis formation
J. Cell Sci., November 1, 2003; 116(21): 4373 - 4390.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Ferri, K. J. Garton, and E. W. Raines
An NF-{kappa}B-dependent Transcriptional Program Is Required for Collagen Remodeling by Human Smooth Muscle Cells
J. Biol. Chem., May 23, 2003; 278(22): 19757 - 19764.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W.-J. Won and J. F. Kearney
CD9 Is a Unique Marker for Marginal Zone B Cells, B1 Cells, and Plasma Cells in Mice
J. Immunol., June 1, 2002; 168(11): 5605 - 5611.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. P. Moiseeva
Adhesion receptors of vascular smooth muscle cells and their functions
Cardiovasc Res, December 1, 2001; 52(3): 372 - 386.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Berditchevski
Complexes of tetraspanins with integrins: more than meets the eye
J. Cell Sci., January 12, 2001; 114(23): 4143 - 4151.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. J. Miller, E. Georges-Labouesse, P. Primakoff, and D. G. Myles
Normal Fertilization Occurs with Eggs Lacking the Integrin {alpha}6{beta}1 and Is CD9-dependent
J. Cell Biol., June 12, 2000; 149(6): 1289 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Nishida, J.-i. Miyagawa, S. Yamashita, S. Higashiyama, A. Nakata, N. Ouchi, R. Tamura, K. Yamamori, S. Kihara, N. Taniguchi, et al.
Localization of CD9, an Enhancer Protein for Proheparin-Binding Epidermal Growth Factor-Like Growth Factor, in Human Atherosclerotic Plaques : Possible Involvement of Juxtacrine Growth Mechanism on Smooth Muscle Cell Proliferation
Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1236 - 1243.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Klein-Soyer, D. O. Azorsa, J.-P. Cazenave, and F. Lanza
CD9 Participates in Endothelial Cell Migration During In Vitro Wound Repair
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 360 - 369.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
A Scherberich, M Campos-Toimil, P Ronde, K Takeda, and A Beretz
Migration of human vascular smooth muscle cells involves serum-dependent repeated cytosolic calcium transients
J. Cell Sci., January 2, 2000; 113(4): 653 - 662.
[Abstract] [PDF]